ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 118 filers reported holding ATEA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $302 | -19.7% | 100,700 | 0.0% | 0.00% | -50.0% |
Q2 2023 | $376 | -60.6% | 100,700 | -64.7% | 0.00% | +100.0% |
Q1 2023 | $954 | +55.1% | 285,600 | +123.3% | 0.00% | -66.7% |
Q4 2022 | $615 | -99.9% | 127,900 | +40.4% | 0.00% | +50.0% |
Q3 2022 | $518,000 | -23.1% | 91,100 | -4.1% | 0.00% | -33.3% |
Q2 2022 | $674,000 | -24.5% | 95,000 | -23.2% | 0.00% | 0.0% |
Q1 2022 | $893,000 | +1.9% | 123,700 | +26.2% | 0.00% | 0.0% |
Q4 2021 | $876,000 | -33.9% | 98,000 | +159.3% | 0.00% | -40.0% |
Q3 2021 | $1,325,000 | +66.5% | 37,800 | +1.9% | 0.01% | +66.7% |
Q2 2021 | $796,000 | +57.3% | 37,100 | +352.4% | 0.00% | +50.0% |
Q1 2021 | $506,000 | +246.6% | 8,200 | +134.3% | 0.00% | +100.0% |
Q4 2020 | $146,000 | – | 3,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tyrus Capital S.A.M. | 1,260,000 | $4,712,400 | 33.11% |
BML Capital Management, LLC | 2,236,239 | $8,363,534 | 7.52% |
TANG CAPITAL MANAGEMENT LLC | 3,026,455 | $11,318,942 | 1.67% |
Stonepine Capital Management, LLC | 752,088 | $2,812,809 | 1.02% |
Bain Capital Life Sciences Investors, LLC | 2,485,638 | $9,296,286 | 0.96% |
CM Management, LLC | 250,000 | $935 | 0.91% |
EcoR1 Capital, LLC | 6,995,861 | $26,164,520 | 0.64% |
Cormorant Asset Management, LP | 1,547,181 | $5,786,457 | 0.32% |
SECTORAL ASSET MANAGEMENT INC | 501,537 | $1,875,748 | 0.31% |
Auour Investments LLC | 177,000 | $661,980 | 0.28% |